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Abstract 
Fatty acid deficiencies are linked to Autism Spectrum 
Disorder. This commentary discusses the protective role 
of breastfeeding and the urgency of research into the 
human infant’s intake of colostrum to prevent fatty acid 
deficiency. 
Keywords:  Autism; Breastfeeding; Fatty Acids; 
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Introduction 
Autistic Spectrum Disorder (ASD) has been growing 
in prevalence over the last decade and new estimates 
suggest that rates in Australia could now be as high as 1 
in 160 children (Williams, MacDermott, Ridley, 
Glasson, & Wray, 2008). Whilst there is no general 
agreement as to the reason/s for the increase, with the 
number of children diagnosed with ASD growing, 
research into the disorder gathers even more urgency 
and the burden on families, health, education and 
welfare services ever greater.  
Research has shown fatty acid deficiencies to be 
over-represented in Attention Deficit Hyperactivity 
Disorder (ADHD), Schizophrenia, Depression, 
Pervasive Developmental Disorder, Developmental 
Coordination Disorder, Epilepsy and, more recently, 
ASD (Bell et al., 2004; Freeman et al., 2006; 
Richardson, 2004; Vancassel et al., 2001). Often found 
in the ASD population are the physical signs of fatty 
acid deficiency including excessive thirst, frequent 
urination, keratosis pilaris on the upper arms or upper 
thighs, dandruff, and atopic tendencies (Bell et al., 
2004), as are lower plasma levels of fatty acids and 
elevated cytosolic PLA2 enzymes compared with 
matched controls (Bell et al., 2004; Richardson, 2004). 
Some researchers, based on clinical reports and 
correlational studies, have gone so far as to propose a 
causal role for a disorder of fatty acid metabolism in 
ASD (Clark-Taylor & Clark-Taylor, 2004; Richardson 
& Ross, 2000). 
If we are to accept that fatty acid deficiency (or a 
fatty acid metabolism impairment) may be relevant in 
ASD (whether as a causal agent, risk factor or 
epiphenomenal biological presence), then it is critically 
important to ensure that an infant has adequate supplies 
of fatty acids in utero and post-natally. The long chain 
polyunsaturated omega-3 and omega-6 fatty acids are 
so essential for the developing foetus that circulating 
levels double in maternal plasma (Crawford, 2000). An 
increase in omega-3 rich seafood in the maternal diet 
during pregnancy has been found to be correlated with 
optimum outcomes for prosocial behaviour, fine motor, 
communication and social development scores in 
children aged from 6 months to 3.5 years of age 
(Hibbeln et al., 2007). Omega-3 and omega-6 fatty 
acids also account for the majority of fats found in 
breast milk (Gibson & Kneebone, 1981). Given this 
fact, it seems reasonable to expect that breastfeeding 
would serve to protect the child from 
neurodevelopmental conditions such as ASD. Indeed, 
this is what studies have found (Schultz et al., 2006; 
Tanoue & Oda, 1989). 
Schultz et al. (2006) surveyed 861 parents of children 
with ASD and 123 parents of children without ASD, 
and found that the children with ASD were significantly 
less likely to have been breastfed. The absence of 
breastfeeding significantly increased the odds of a later 
ASD diagnosis (OR 2.48, 95% CI 1.42, 4.35). The 
apparent link between ASD and breastfeeding was first 
cogently addressed by Tanoue and Oda (1989), who 
found that a significant number of infants subsequently 
diagnosed with an ASD had been weaned within one 
week of the commencement of breastfeeding with the 
duration of breastfeeding proposed as a protective 
factor. Similarly, the odds of being diagnosed with 
ASD also reduced with the duration of breastfeeding in 
the Schultz et al study, but not significantly. One major 
limitation of both of these studies is that colostrum 
intake was not accounted for.  
In humans, and all mammals, lactation has three 
distinct stages: colostrum, transitional milk and mature 
milk, and at each stage the composition of the milk 
differs (Davis et al., 2007). Colostral milk contains 
immunoglobulins such as IgA, which play an important 
role in gut mucosal immunity (Vassilev & Veleva, 
1996), and a higher level of protein than mature milk 
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(Davis et al., 2007). Colostrum also contains twice the 
long chain polyunsaturated fatty acids of mature milk 
and this is consistent in all lactating women in all parts 
of the world (Fidler & Koletzko, 2000). Hence 
colostrum can supply the breastfed neonate with 
significant amounts of preformed fatty acids during the 
first few days after birth even though the total milk 
intake is less than a mature milk feed (Fidler & 
Koletzko, 2000). 
The World Health Organization (WHO) definition of 
exclusive breastfeeding is that the infant only receives 
breast milk without any additional food or drink, not 
even water, on demand day and night for the first six 
months of life (WHO, 2009). The remainder of the 
WHO guidelines lead to a critical issue for researchers 
in this field: that is, the recommendation that initiation 
of breastfeeding takes place within the first hour of life 
(italics added). Adherence to the WHO 
recommendation ensures that infants are able to access 
and utilise the preformed and highly digestible omega-6 
and omega-3 fatty acids found in colostrum 
immediately after birth. As the timing of the 
establishment of breast feeding varies due to a number 
of circumstances, especially in premature babies, it is 
critical to determine whether infant fatty acid status 
and/or metabolism can be compromised by a lack of 
colostrum in the early stages after birth. An indication 
of the seriousness with which this issue should be taken 
is provided by numerous animal studies that have 
demonstrated fatty acid metabolism impairments and 
fatty acid deficiencies to be linked to low colostral 
intake. For example, the best protection for newborn 
piglets, calves and horses is immediate colostral feeding 
followed by an extended period of suckling over many 
weeks (Baxter, Baxter, & MacCormack, 1983; Gerrard, 
1974). One study of neonatal calves found that delaying 
their colostral intake by just 24 hours impaired their 
fatty acid, carotene, retinol and alpha-tocopherol status 
(Blum, Hadorn, Sallmann, & Schuep, 1997). 
Concentrations of fatty acids and fat-soluble vitamins in 
colostrum decrease as the time since parturition 
increases, and the infant calves’ absorptive capacity is 
decreased due to gut closure. In animals, there is clear 
evidence of a critical timeframe (24 hours post-birth) 
where colostrum must be accessed to ensure optimal 
fatty acid metabolism (Blum et al., 1997).   
In stark contrast to the well accepted norms of animal 
management, the importance of colostrum ingestion in 
human infants is largely overlooked. If a human infant 
does not receive the fatty acid rich colostrum in a 
timely fashion, does this interrupt the establishment of a 
functional fatty acid metabolism as it seems to for 
animals? It would strike us as unusual if it didn’t but, at 
this point, there is no way of answering the question 
definitively. One human study (Vukavic, 1984) found 
that if the initiation of breastfeeding is postponed, 
spontaneous gut closure may not take place within the 
first 30 hours leaving the infant exposed to potential 
environmental contaminants (Blum et al., 1997). As 
colostrum is known to be implicated in the process of 
gut closure (Blum et al., 1997; Vukavic, 1984), infants 
who do not receive colostrum may have their health 
compromised by a delay in gut closure and a reduction 
in essential fatty acids. 
This issue may be particularly important for 
premature infants who are invariably fatty acid depleted 
at birth due to the bulk of Docosahexaenoic Acid 
(DHA) accretion into the brain and central nervous 
system (CNS) occurring via the placenta in the last 
trimester of pregnancy (Makrides et al., 2009).  
Makrides et al. found that premature infant girls 
supplemented with a high level of DHA performed 
better at 18 months of age on the Mental Development 
Index of the Bayley Scales of Infant Development than 
non-supplemented peers. No such effect was found for 
males, however. Unfortunately, no information is given 
in regard to infant colostral intake. Of interest is the 
finding that females, in comparison to males, 
metabolise fatty acids at a rate of 4 to 1 (Burdge, 2004) 
seemingly due to the fact that testosterone can inhibit 
fatty acid synthesis (Marra & de Alaniz, 1989) and that 
both prematurity and male gender are independent risk 
factors for ASD (Kolevzon, Gross, & Reichenberg, 
2007).  
Pragmatic and/or medical issues prevent 
breastfeeding to WHO guidelines in all cases. 
Therefore, a critical research question relates to whether 
the current practice of not attempting to substitute for 
colostrum and moving directly to a mature milk 
replacement (formula) is the most effective approach to 
take for infants unable to be breastfed. Until 2002, if 
fatty acids were found in formula they were in the form 
of Linoleic Acid (LA) the omega-6 precursor to 
Arachidonic Acid (AA) and alpha Linolenic Acid 
(ALA) the omega-3 precursor to DHA (Alessandri et 
al., 2004). This led Alessandri et al. to make the 
observation that as infants have a limited capacity to 
synthesise DHA from ALA (which reduces with 
gestational age), artificially fed human infants are the 
only mammals that do not receive 20 and 22 carbon 
polyunsaturated fatty acids during their first months of 
life (Alessandri et al., 2004). Since 2002, DHA and AA 
have been included in selected infant formulas, 
although unsupplemented formulas are still widely 
available.  
Infants fed unsupplemented formula have been 
shown to have lower DHA in their CNS, plasma and 
red blood cells, and autopsy studies have shown that 
these infants show depletion of their adipose tissue 
DHA stores by six months of age, whilst breastfed 
infants have maintained their DHA levels (Sarkadi-
Nagy et al., 2004). Simply adding fatty acids to formula 
is a complex process, however, as dietary fatty acids 
synthesise via metabolic competition and a dietary 
source of one can deplete the synthesis of another 
(Sarkadi-Nagy et al., 2004). In a study of term and 
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preterm baboon neonates designed to measure the 
effects of supplementing formula with DHA and AA, 
supplemented formula was shown to partially restore 
the biosynthesis of DHA/AA to lower breastfed levels 
but the commonly available formula DHA 
concentrations were found to be inadequate to ensure a 
complete match of breastfed levels (Sarkadi-Nagy et al., 
2004). The use of infant formula without DHA or AA 
supplementation versus exclusive breastfeeding was 
also significantly associated with an increase in ASD in 
the Schultz et al. (2006) study (OR 4.41, 95% CI 1.27, 
15.7). Despite the limitations of the study (non-random 
sample and self-reported infant feeding practices) there 
appears to be mounting evidence that fatty acids serve a 
protective function in regard to the development of a 
number of neurodevelopmental disorders (Crawford, 
2000; Richardson, 2004). 
Clinical trials of fatty acids as a treatment in ASD are 
in their infancy and clear protocols regarding form of 
fatty acid, dose and agreement on adequate placebos in 
research trials require further clarification (Richardson, 
2004). Furthermore, research in this field in the future 
would be greatly improved by ensuring thorough 
documentation of fatty acid intake beyond superficial 
examinations of intake in supplemental form. 
Specifically, researchers must examine colostral and 
mature milk intake separately, and also consider the 
source of any fatty acid supplementation and the 
relative ratios of the major fatty acid types (particularly 
of omega-3 to omega-6). With a more thorough 
understanding of fatty acid metabolism and its role in 
development, new and effective preventative and 
treatment measures are possible, not only with 
relevance to ASD, but other developmental conditions 
such as learning disorders and ADHD.    
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